Two River is a venture capital firm in New York that focuses on the life science sector. Founded 2004 in New York, United States, it invests in early stage ventures, late stage ventures, and seed. Its portfolio companies include amunix, Thirty Madison, Keeps, Willow, Hubble Contacts, Allogene Therapeutics, and Andie. As of April 2020, Two River has made 16 investments. Their most recent investment was on March 4, 2020, when amunix raised $73M. Two River has had five exits, the most notable of which include Kite Pharma, Sienna Biopharmaceuticals, and UroGen Pharma. Kite Pharma is a development-stage biotechnology company designing and developing immune-based therapies to treat cancer indications. Sienna Biopharmaceuticals is a company that does clinical development and commercialization of innovative aesthetics and medical dermatology products based on scientific breakthroughs. UroGen Pharma is a clinical-stage biopharmaceutical company.